Summary

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.

The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.

The public comment period ends on May 7, after which the FDA may finalize the ban.

  • @hedgehogging_the_bed
    link
    1613 days ago

    Oooo! Do Guaifenesin next! That also has basically no evidence of effectiveness despite being on the market for ages.

    • peopleproblems
      link
      513 days ago

      That I didn’t know. Does that mean that the benefit from it just comes from drinking the insane amount of water it recommends?

    • quicklime
      link
      fedilink
      513 days ago

      Guaifenesin works very very well for me as an expectorant.